On-Demand version of the July 10, 2019 eCast.
Please note: This is a Single Viewer On-Demand eCast available for one registrant to access the on-demand version of the eCast. Once registered, access is granted via the AABB Education Website located at https://education.aabb.org.
Program Description: Platelet transfusion refractoriness is an increasing issue in heavily transfused patients such as patients with hematologic malignancies. The blood bank and HLA laboratory play an important role in assessing clinical refractoriness and helping clinicians determine whether there is an immune or non-immune etiology (or both). Dr. Peña will describe his institution’s approach to the platelet refractory patient.